eGene Announces Initial Product Test Milestone of Its Carbohydrate Analyzer

eGene's trading chart for today:




IRVINE, Calif.--eGene Inc. (OTCBB:EGEI - News), developer of revolutionary high-performance bio-analytical instruments, announced today that a new instrument has been developed for carbohydrate analysis and sequencing. The fully functional system has been tested by Prof. Andras Guttman, Marie Curie Chair of the European Commission, head of the Horvath Laboratory of Bioseparation Sciences in the University in Innsbruck, Austria.


Prof. Andras Guttman, a known expert in carbohydrate analysis, has been collaborating with eGene in the development of the multicapillary carbohydrate analyzer. Initial result of the test will be presented at the Latin American Capillary Electrophoresis Conference (LACE 2006) at Queretaro, Mexico (Dec. 2-5, 2006).

Professor Guttman noted: "eGene's new Carbohydrate Analyzer provides rapid and high resolution analysis of complex sugars, and holds the promise of becoming the first automated carbohydrate sequencer. The automated, multicapillary electrophoresis technology platform will support numerous applications in proteomics research for the biotechnology, pharmaceutical (drug development) and food analysis industries."

Mr. Varouj Amirkhanian, EVP/Director of R&D at eGene, noted: "The new carbohydrate analyzer was developed based on our patented multichannel fluorescence detection technology. It provides compact, automated, high throughput digital detection for the analysis of simple and complex carbohydrate mixtures. It saves time and material cost, and it will as well provide much higher resolving power than the currently used traditional slab gel electrophoresis or HPLC type devices on the market."

Dr. Ming Liu, CEO of eGene, noted: "Carbohydrates formerly considered as storehouses for energy or structural material in cell membranes now appear to play a significant role in important biological functions such as pathogen recognition and ovum fertilization. The new carbohydrate analyzer is the next generation bioanalyzer that has been developed by eGene's R&D team. We plan to launch the product in early 2007. eGene is currently starting early marketing and worldwide commercialization of the system."